Comparison of karyotypes
| Karyotype . | AML/MDS, n = 511 (%) . | tMDS/tAML, n = 13 (%) . | P . |
|---|---|---|---|
| Samples | |||
| Satisfactory | 53% | 54% | 1.0 |
| Reviewed and rejected | 20% | 13% | .448 |
| Missing | 27% | 33% | .487 |
| Normal/constitutional | 128 (25) | 2 (15) | .53 |
| t(8;21); t(15;17); 16q22 | 122 (24) | 0 | .05 |
| 11q23 | 78 (15) | 3 (23) | .44 |
| del (7); 7q- | 31 (6) | 2 (15) | .19 |
| + 8 | 35 (7) | 3 (28) | .06 |
| + 21 | 11 (2) | 0 | 1.00 |
| Hyperdiploid | 14 (3) | 2 (15) | .06 |
| Hypodiploid | 10 (2) | 0 | 1.00 |
| Other | 82 (16) | 1 (8) | .70 |
| Karyotype . | AML/MDS, n = 511 (%) . | tMDS/tAML, n = 13 (%) . | P . |
|---|---|---|---|
| Samples | |||
| Satisfactory | 53% | 54% | 1.0 |
| Reviewed and rejected | 20% | 13% | .448 |
| Missing | 27% | 33% | .487 |
| Normal/constitutional | 128 (25) | 2 (15) | .53 |
| t(8;21); t(15;17); 16q22 | 122 (24) | 0 | .05 |
| 11q23 | 78 (15) | 3 (23) | .44 |
| del (7); 7q- | 31 (6) | 2 (15) | .19 |
| + 8 | 35 (7) | 3 (28) | .06 |
| + 21 | 11 (2) | 0 | 1.00 |
| Hyperdiploid | 14 (3) | 2 (15) | .06 |
| Hypodiploid | 10 (2) | 0 | 1.00 |
| Other | 82 (16) | 1 (8) | .70 |
Cytogenetic analysis was recommended but not a requirement for study entry.